| 000 | 01893 a2200625 4500 | ||
|---|---|---|---|
| 005 | 20250515192656.0 | ||
| 264 | 0 | _c20100225 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1399-0004 | ||
| 024 | 7 |
_a10.1111/j.1399-0004.2009.01277.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGhadirian, P | |
| 245 | 0 | 0 |
_aThe contribution of founder mutations to early-onset breast cancer in French-Canadian women. _h[electronic resource] |
| 260 |
_bClinical genetics _cNov 2009 |
||
| 300 |
_a421-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aCheckpoint Kinase 2 |
| 650 | 0 | 4 | _aFanconi Anemia Complementation Group N Protein |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFounder Effect |
| 650 | 0 | 4 |
_aFrance _xethnology |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aQuebec _xepidemiology |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aRobidoux, A | |
| 700 | 1 | _aZhang, P | |
| 700 | 1 | _aRoyer, R | |
| 700 | 1 | _aAkbari, M | |
| 700 | 1 | _aZhang, S | |
| 700 | 1 | _aFafard, E | |
| 700 | 1 | _aCosta, M | |
| 700 | 1 | _aMartin, G | |
| 700 | 1 | _aPotvin, C | |
| 700 | 1 | _aPatocskai, E | |
| 700 | 1 | _aLarouche, N | |
| 700 | 1 | _aYounan, R | |
| 700 | 1 | _aNassif, E | |
| 700 | 1 | _aGiroux, S | |
| 700 | 1 | _aNarod, S A | |
| 700 | 1 | _aRousseau, F | |
| 700 | 1 | _aFoulkes, W D | |
| 773 | 0 |
_tClinical genetics _gvol. 76 _gno. 5 _gp. 421-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-0004.2009.01277.x _zAvailable from publisher's website |
| 999 |
_c19253102 _d19253102 |
||